Company Performance Metrics
Paradigm Biodevices has been committed to advancing MIS solutions for patients and doctors since 1997. Paradigm’s leading product, the quickdraw MIS bone harvester, was launched in the midst of widespread expansion in the use of bone substitutes due to concerns over donor site morbidity. Rather than develop another bone substitute, Paradigm
conducted pre-market surveys to investigate the underlying causes of donor site morbidity. Following the findings, Paradigm advanced MIS techniques to provide more favorable outcomes – the result was the development of the quickdraw MIS bone harvester. Since 2009, clinical data has supported the safety and efficacy of MIS iliac crest bone harvesting yielding results that refute earlier clinical data. ICBG, the "gold standard," now represents a natural and effective option for excellent clinical outcomes, lower costs, and favorable professional reimbursement.
